NEWS

Sotac Pharmaceuticals Limited IPO : Key Details

Sotac Pharmaceuticals Limited IPO is set to launch on 29 March, 2023. It manufactures pharmaceutical products for other companies on the basis of a contract or loan license. It has more than 162 corporate clients across countries on a loan license or contract manufacturing. Its manufacturing facility was established in the year 2017. It has the capacity for manufacturing 90 Crore tables per year and 14 Crore Capsules per year. It’s a part of the SOTAC Group which is based in Gujarat and has an experience of 59 years in the field.

Sotac Pharmaceuticals Limited IPO DETAILS

Sotac Pharmaceuticals Limited IPO is set to launch on 29 March., 2023. The subscription timeline extends till 3 April, 2023. The size for the IPO is 33.30 Crore Rs. Shares issued through fresh issue mode are worth 33.30 Crore Rs. No Shares are issued through offer for sale mode. The lot size is 1200 shares and the price is 105 to 111 Rs per share. The company is going to get listed at NSE SME. The face value per share is Rs.10 and this is a Book Built issue. The registrar for the company is KFin Technologies Limited.

Tabular Description of Sotac Pharmaceuticals Limited IPO

IPO OPENING DATE	29 March., 2023
CLOSING DATE FOR IPO	3 April, 2023
ISSUE TYPE	Book Built Issue
Face Value per share	10 Rs. per share
IPO price band	105 to 111 Rs per share
LOT SIZE	1200 shares
MINIMUM ORDER QUANTITY	1200 shares
ISSUE SIZE	33.30 Crore Rs.
OFFER FOR SALE	No shares are issued through offer for sale mode.
FRESH ISSUE	33.30 Crore Rs.
LISTING AT	NSE SME
LISTING DATE	13 April, 2023

Sotac Pharmaceuticals Limited IPO : IMPORTANT DATES

IPO OPENING DATE	29 March., 2023
CLOSING DATE FOR IPO	3 April., 2023
IPO ALLOTMENT DATE	10 April, 2023
REFUNDS	11 April, 2023
DEMAT A/C CREDITED ON	12 April, 2023
IPO LISTING DATE	13 April, 2023

Sotac Pharmaceuticals Limited IPO begins for subscription from 29 March., 2023. The IPO subscription would continue till 3 April, 2023. The allotment status for the shareholders who applied would come on 10 April, 2023. The refunds for the ones who did not get allotment would be initiated on 11 April, 2023. The DEMAT accounts of shareholders would be credited on 12 April, 2023. The listing of the company would be accompanied on 13 April, 2023.

Sotac Pharmaceuticals Limited IPO : Lead Managers

The lead managers are :

Beeline Capital Advisors Private Limited

The minimum lot size for the company is decided at 1200 shares. This holding accounts to 133200 Rs.. The maximum lot size is decided at 2400 shares (HNI). This amounts to 266400 Rs.. Hence the company’s final holdings would be set as :

	Shares	Amount
Minimum	1200 shares	133200 Rs.
Maximum	2400 shares	266400 Rs.

OBJECTIVES FOR THE IPO

IPO proceeds would be used for general corporate purposes.
The IPO Money will be used for investment into a company’s subsidiary.
The money will be used for upgrading and constructing the current building of the firm.
The Issue proceeds will be utilised for fulfilling the working capital requirements.

COMPANY FINANCIALS

Particularly (in Lakh Rs.)	2019-20	2020-21	2021-22
ASSETS	3038	3470	3525
Revenue	2882	4895	7337
PAT	8.75	(-237)	289

Sotac Pharmaceuticals Limited had an asset base of 3038 Lakh Rs in 2020 which increased to 3470 Lakh Rs in 2021 and 3525 Lakh Rs in 2022. The company had a revenue base of 2882 Lakh Rs in 2020 which increased by 1.7 times to 4895 Lakh Rs. The revenue increased by 1.5 times to 7337 Lakh Rs in 2022 from 4895 Lakh Rs. The profit of the firm was 8.75 Lakh Rs. However the company made a loss of 237 Lakh Rs in 2021. However the company made 289 Lakh Rs in profits in the year 2022.

PROS

Sotac Pharmaceuticals Limited has more than 162 corporate clients across countries on a loan license or contract manufacturing. Its manufacturing facility was established in the year 2017.
It has the capacity for manufacturing 90 Crore tables per year and 14 Crore Capsules per year.
It’s a part of the SOTAC Group which is based in Gujarat and has an experience of 59 years in the field.